HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: Implications for pathogenesis and transmission

Virology

Volumn 253, Issue 1, 1999, Pages 10-16

  Dornadula, Geethanjali ^a   Zhang, Hui ^a   Shetty, Shubhra ^a   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

HIV 1; Infectivity; Intravirion; Reverse transcription

Indexed keywords

ZIDOVUDINE;

ARTICLE; CELL DIVISION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRION; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0033524339     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9465     Document Type: Article

References (28)

1. Arthur, L. O., Bess, J. W., Jr., Sowder, R. C., II, Benveniste, R. E., Mann, D. L., Chermann, J-C., and Henderson, L. E. (1992). Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 258, 1935-1938.
2. Baboonian, C., Dalgleish, A., Bountiff, L., Gross, J., Oroszlan, S., Rickett, G., Smith-Burchnell, C., Troke, P., Merson, J., Troke, P., and Merson, J. (1991). HIV-1 proteinase is required for synthesis of proviral DNA. Biochem. Biophys. Res. Commun. 179, 17-24.
3. Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P., and Stevenson, M. (1991). Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
4. Collin, M., and Gordon, S. (1994). The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology 200, 114-120.
5. Collman, R., Hassn, N. F., Walker, R., Godfrey, B., Cutilli, J., Hastings, J. C., Friedman, H., Douglas, S. D., and Nathanson, N. (1989). Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 170, 1149-1163.
6. Dornadula, G., Zhang, H., Bagasra, O., and Pomerantz, R. J. (1997). Natural endogenous reverse transcription (NERT) of simian immunodeficiency virus (SIV). Virology 227, 260-267.
7. Fortin, J-F., Cantin, R., Lamontagne, G., and Tremblay, M. (1997). Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71, 3588-3596.
8. Fuetterer, J., and Hohn, T. (1987). Involvement of nucleocapsids in reverse transcription: A general phenomenon. Trends Biochem. Sci. 12, 92-95.
9. Gao, W. Y., Cara, A., Gallo, R. C., and Lori, F. (1993). Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit. Proc. Natl. Acad. Sci. USA 90, 8925-8928.
10. Lori, F., Veronese, F. M., De Vico, A. L., Lusso, P., Reitz, M. S., and Gallo, R. C. (1992). Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66, 5067-5074.
11. Meyerhans, A., Vartanian, J-P., Hultgren, C., Plikat, U., Karlsson, A., Wang, L., Eriksson, S., and Wain-Hobson, S. (1994). Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68, 535-540.
12. Miller, C. J., Marthas, M., Greenier, J., Lu, D., Dailey, P. J., and Lu, Y. (1998). In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J. Virol. 72, 3248-3258.
13. Miller, C. J., Vogel, P., Alexander, N. J., Sutjipto, S., Hendricks, A. G., and Marx, P. A. (1992). Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am. J. Pathol. 141, 655-660.
14. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
15. O'Brien, W. A., Namazi, A., Kalhor, H., Mao, S., Zack, J. A., and Chen, I. S. Y. (1994). Kinetics of human immunodeficiency virus type 1 reverse transcription in the blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68, 1258-1263.
16. Spina, C. A., Guatelli, J. C., and Richman, D. D. (1995). Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 positive lymphocytes in vitro. J. Virol. 69, 2977-2988.
17. Spira, A. I., Marx, P. A., Patterson, B. K., Mahoney, J., Koup, R. A., Wolinsky, S. M., and Ho, D. D. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225.
18. Trono. D. (1992). Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66, 4893-4900.
19. Yong, W. H., Wyman, S., and Levy, J. A. (1990). Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction. AIDS 4, 199-206.
20. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., and Chen, I. S. Y. (1990). HIV-1 entry into quiescent primary lymphocytes molecular analysis reveals a labile, latent viral structure. Cell. 61, 213-222.
21. Zack, J. A., Haislip, A. M., Krogstad, P., and Chen, I. S. Y. (1992). Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life-cycle. J. Virol. 66, 1717-1725.
22. Zhang H., Bagasra, O., Niikura, M., Poiesz, B. J., and Pomerantz, R. J. (1994). Intravirion reverse transcripts in the peripheral blood plasma of HIV-1 infected individuals. J. Virol. 68, 7591-7597.
23. Zhang, H., Dornadula, G., and Pomerantz, R. J. (1996a). Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenvironments: An important stage for viral infection of nondividing cells. J. Virol. 70, 2809-2824.
24. Zhang, H., Dornadula, G., Wu, Y., Havlir, D., Richman, D. D., and Pomerantz, R. J. (1996b). Kinetic analysis of intravirion reverse transcription in blood plasma of human immunodeficiency virus type 1-infected individuals: Direct assessment of resistance to reverse transcriptase inhibitors in vivo. J. Virol. 70, 628-634.
25. Zhang, H., Dornadula, G., Alur, P., Laughlin, M. A., and Pomerantz, R. J. (1996c). Amphiphathic domains in the C-terminus of the transmembrane protein (gp41), permeabilize HIV-1 virions: A molecular mechanism underlying natural endogenous reverse transcription. Proc. Natl. Acad. Sci. USA 93, 12519-12524.
26. Zhang, H., Duan, L.-X., Dornadula, G., and Pomerantz, R. J. (1995a). Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: Potential utility for genetic therapies. J. Virol. 69, 3929-3932.
27. Zhang, H., Zhang, Y., Spicer, T. P., Henrard, D., and Poiesz, B. J. (1995b). Nascent reverse transcription occurs in the enveloped particle. J. Virol. 69, 3675-3682.
28. Zhang, H., Zhang, Y., Spicer, T. P., Abbott, L. Z., and Poiesz, B. J. (1993). Reverse transcription takes place within extracellular HIV-1 virions: Potential biological significance. AIDS Res. Hum. Retroviruses 9, 1287-1296.